| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/04/2002 | US6399371 Human matrix metalloprotease gene, proteins encoded therefrom and methods of using same |
| 06/04/2002 | US6399370 Compositions and methods for use of defensin |
| 06/04/2002 | US6399369 Multipotent neural stem cell cDNA libraries |
| 06/04/2002 | US6399348 DNA sequences for matrix metalloproteases, their production and use |
| 06/04/2002 | US6399345 Subunits of NADH dehydrogenase |
| 06/04/2002 | US6399343 Amino acid sequence of gene from streptococcus; drug screening for bactericides |
| 06/04/2002 | US6399333 Process for producing erythropoietin containing no animal proteins |
| 06/04/2002 | US6399328 Amino acid sequence; hybridization probes; amplification primers; anticarcinogenic agents; antitumor agents |
| 06/04/2002 | US6399327 Dna sequence which codes for specific amino acid sequence of a polypeptide capable of binding to mort-1 which in turn binds to intracellular domain of fas receptor |
| 06/04/2002 | US6399326 Nucleic acid which encodes polypeptide of defined amino acid sequence which has a cysteine motif |
| 06/04/2002 | US6399322 Identifying proteins from t helper 2 cells that interact with maf family proteins using indicator cells with reporter gene linked to a transcriptional regulatory sequence which binds maf family proteins |
| 06/04/2002 | US6399316 PACAP receptor protein, method for preparing said protein, and use thereof |
| 06/04/2002 | US6399315 Drug screening by contacting cells transfected with nucleic acid encoding a g-protein coupled receptor which binds corticotropin-releasing factor, then monitoring cell for compounds which bind the receptor |
| 06/04/2002 | US6399301 Amino acid sequence; diagnosis of cancer and inflammation; antiinflammatory agents; anticarcinogenic agents |
| 06/04/2002 | US6399294 Probes; primers; immunogens; for diagnosis of human immunodeficiency virus infections |
| 06/04/2002 | US6399114 Nutritional system for nervous system disorders |
| 06/04/2002 | US6399103 Dispersing physiologically active polypeptide into biodegradable polymer and zinc oxide; high entrapment ratio; high blood concentration levels over extended period |
| 06/04/2002 | US6399101 Levothyroxine sodium and silicified microcrystalline cellulose; tablets; light, heat, and humidity stable |
| 06/04/2002 | US6399098 Composition for treating dental caries caused by streptococcus mutans |
| 06/04/2002 | US6399097 Composition for treatment of a bacterial infection of the digestive tract |
| 06/04/2002 | US6399090 Insulin supplemented infant formula |
| 06/04/2002 | US6399079 Spill resistant pharmaceutical compositions in semi-solid form |
| 06/04/2002 | US6399078 Chemokine—glycosaminoglycan complexes and their use in treating or preventing receptor mediated diseases |
| 06/04/2002 | US6399075 Peptide sequences for viricides |
| 06/04/2002 | US6399071 Removal of xenobodies from body fluid |
| 06/04/2002 | US6399070 Heat shock protein complex for immunology |
| 06/04/2002 | US6399069 Purification and prevention of disease with heat shock protein bound to antigens |
| 06/04/2002 | US6399068 Cancer treatment, interleukins, fusion proteins, cell markers |
| 06/04/2002 | US6399067 Methods and compositions for impairing multiplication of HIV-1 |
| 06/04/2002 | US6399066 Capsular polysaccharide adhesin antigen, preparation, purification and use |
| 06/04/2002 | US6399065 Methods for modulating SLAM-expressing T cells |
| 06/04/2002 | US6399064 Cloning endothelial cells and protein c |
| 06/04/2002 | US6399063 Monoclonal antibodies directed to the HER2 receptor |
| 06/04/2002 | US6399061 Monoclonal secreted by atcc deposit no. hb11388 and transfectoma tcae8 accorded atcc deposit no. 69119; parenteral injection |
| 06/04/2002 | US6399059 Thermally stable enzyme composition and method of preparing the same |
| 06/04/2002 | US6399058 Methods for treating ocular diseases |
| 06/04/2002 | US6399053 Methods of enhancing bioactivity of chemokines |
| 06/04/2002 | US6398816 Genetic engineering of cells to enhance healing and tissue regeneration |
| 06/04/2002 | US6398757 Gene therapeutic treatment of blood vessel associated disorders |
| 06/04/2002 | US6397849 Methods of ophthalmic administration |
| 06/04/2002 | CA2361950A1 Antibiotics g 23077, pharmaceutically acceptable salts and compositions, and use thereof |
| 06/04/2002 | CA2205198C Human neutrophil elastase inhibitors |
| 06/04/2002 | CA2174097C Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| 06/04/2002 | CA2171424C Acylated insulin |
| 06/04/2002 | CA2119262C Compositions comprising a bactericidal/permeability increasing protein and a lipid carrier, methods of making same, and uses thereof |
| 06/04/2002 | CA2078990C Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs |
| 06/04/2002 | CA2076593C Polypeptides and use thereof |
| 06/04/2002 | CA1341364C Single polypeptide chain binding molecules |
| 06/03/2002 | WO2002000202A1 Endoparasiticidal agents for voluntary oral ingestion by animals |
| 06/01/2002 | CA2325666A1 Immunogenic mutated peptides derived from r9m, polynucleotides, coding polynucleotides and their therapeutic uses |
| 05/30/2002 | WO2002042777A2 Modulation of the interaction between evh1 domains |
| 05/30/2002 | WO2002042776A2 Compositions and methods relating to prostate specific genes and proteins |
| 05/30/2002 | WO2002042772A1 TRIPEPTIDE OF FCηRIIA |
| 05/30/2002 | WO2002042489A1 Methods involving a t cell protein tyrosine phosphatase |
| 05/30/2002 | WO2002042462A2 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 05/30/2002 | WO2002042460A2 Compositions and methods relating to colon specific genes and proteins |
| 05/30/2002 | WO2002042458A2 G protein coupled receptors |
| 05/30/2002 | WO2002042457A1 Cloning and expression of human slap-2: a novel sh2/sh3 domain-containing human slap homologue having immune cell-specific expression |
| 05/30/2002 | WO2002042456A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/30/2002 | WO2002042455A2 Modifier of organelle metalbolism |
| 05/30/2002 | WO2002042453A1 A novel polypeptide, a human big protein 0767-19.36 and the polynucleotide encoding the polypeptide |
| 05/30/2002 | WO2002042452A2 Adapter protein and gene encoding it |
| 05/30/2002 | WO2002042449A2 Method for selecting peptide ligands |
| 05/30/2002 | WO2002042448A1 Novel polypeptide |
| 05/30/2002 | WO2002042445A2 Differentiated cells suitable for human therapy |
| 05/30/2002 | WO2002042444A2 Fungal gene cluster associated with pathogenesis |
| 05/30/2002 | WO2002042441A2 VON WILLEBRAND FACTOR (vWF) CLEAVING PROTEASE POLYPEPTIDE, NUCLEIC ACID ENCODING THE POLYPEPTIDE AND USE OF POLYPEPTIDE |
| 05/30/2002 | WO2002042439A2 Aggrecanase adamts9 |
| 05/30/2002 | WO2002042438A2 Human kinases and polynucleotides encoding the same |
| 05/30/2002 | WO2002042437A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/30/2002 | WO2002042436A2 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof |
| 05/30/2002 | WO2002042435A2 Regulation of human tyrosine phosphatase |
| 05/30/2002 | WO2002042425A2 Antisense modulation of mp-1 expression |
| 05/30/2002 | WO2002042423A2 Antisense modulation of src-2 expression |
| 05/30/2002 | WO2002042422A2 Molecular interactions in hematopoietic cells |
| 05/30/2002 | WO2002042420A2 Modulation of gene expression during intimal hyperplasia of the carotid artery |
| 05/30/2002 | WO2002042415A2 Agents for blocking t cell mediated immune reactions |
| 05/30/2002 | WO2002042414A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 05/30/2002 | WO2002042413A2 Methods and compositions involved in groucho-mediated differentiation |
| 05/30/2002 | WO2002042412A2 Protease inhibitors and their pharmaceutical uses |
| 05/30/2002 | WO2002042336A2 Fgf-affinity chromatography |
| 05/30/2002 | WO2002042332A2 Truncated cd200 |
| 05/30/2002 | WO2002042331A1 Basic fibroblastic growth factor with a specific collagen binding domain |
| 05/30/2002 | WO2002042330A2 Cystoskeleton-associated proteins |
| 05/30/2002 | WO2002042329A2 Compositions and methods relating to prostate specific genes and proteins |
| 05/30/2002 | WO2002042327A2 Cocoa albumin and its use in the production of cocoa and chocolate flavour |
| 05/30/2002 | WO2002042321A2 Mixed fibrils |
| 05/30/2002 | WO2002042316A2 Pna analogues |
| 05/30/2002 | WO2002042295A2 Peptides as met-ap2 inhibitors |
| 05/30/2002 | WO2002042278A2 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 05/30/2002 | WO2002042118A2 Oil maintenance indicator |
| 05/30/2002 | WO2002041922A1 Method of regulating the activity of expression product of gene transferred into living body |
| 05/30/2002 | WO2002041912A1 Drugs and foods improving the quality of life and process for producing the same |
| 05/30/2002 | WO2002041911A2 Use of fgf-19 for inhibiting angiogenesis |
| 05/30/2002 | WO2002041910A2 Methods and compositions for the treatment of diseases of the eye |
| 05/30/2002 | WO2002041901A1 Treatment of osteoporosis |
| 05/30/2002 | WO2002041859A1 Use of cyclosporin a 7-thioamide derivatives for hair growth |
| 05/30/2002 | WO2002041858A1 Use of cyclosporin 7-thioamide derivatives for hair growth |
| 05/30/2002 | WO2002041837A2 Treatment of mucositis |
| 05/30/2002 | WO2002041836A2 Antisense modulation of src-1 expression |